Spindle cell carcinoma of the breast: A case report and an immunohistochemical study including p53 and Ki-67 expression

Pathology International

Volumn 47, Issue 6, 1997, Pages 404-411

  Nakayama, Yoshifuku ^a   Iwasaki, Hiroshi ^a   Iwanaga, Shin Ichi ^a   Nakamura, Hiroshi ^a   Shiroshita, Toyoo ^a   Kikuchi, Masahiro ^a   Jozaki, Hiroshi ^b   Hashimoto, Mikitoshi ^b   Ikeda, Seiyo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Hakujuji Hospital   (Japan)

Author keywords

Ki 67; metaplastic carcinoma; p53; spindle cell carcinoma

Indexed keywords

ALPHA ACTIN; KI 67 ANTIGEN; PROTEIN P53; PROTEIN S 100; VIMENTIN;

ADULT; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CASE REPORT; ELECTRON MICROSCOPY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LABELING INDEX; PRIORITY JOURNAL; SPINDLE CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 0030918896     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04515.x     Document Type: Article

References (25)

1. Oberman HA. Metaplastic carcinoma of the breast: A clinicopathologic study of 29 patients. Am. J. Surg. Pathol. 1987; 11: 918-929.
2. World Health Organization. Histological typing of breast tumors, 2nd ed. International Histological Classification of Tumours, No. 2. World Health Organization, Geneva, 1981.
3. Foschini MP, Dina RE, Eusebi V. Sarcomatoid neoplasms of the breast: proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Semin. Diagn. Pathol. 1993; 10: 128-136.
4. Enghardt MH, Hale JH. An epithelial and spindle cell breast tumour of myoepithelial origin: An immunohistochemical and ultrastructural study. Virchows Arch. A Pathol. Anat. Histopathol. 1989; 416: 177-184.
5. Bartek J, Iggo R, Gannon J, Lane DP. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990; 5: 893-899.
6. Bartek J, Bartkova J, Vojtesek B et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991; 6: 1699-1703.
7. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
8. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523-526.
9. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors: An immunohistochemical study using methacarn-fixed, embedded tissue. Am. J. Pathol. 1992; 140: 145-153.
10. Allred DC, Clark GM, Elledge R et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. Natl Cancer Inst. 1993; 85: 200-206.
11. Coles C, Condie A, Chotty U, Steel CM, Evans HJ, Prasser J. p53 mutations in breast cancer. Cancer Res. 1992; 52: 5291-5298.
12. Hurlimann J, Chaubert P, Benhattar J. p53 gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: Correlation between immunohistochemical and molecular biology techniques. Mod. Pathol. 1994; 7: 423-428.
13. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc60-p53 complex with an altered half-life. Mol. Cell Biol. 1988; 8: 531-539.
14. Costa A, Marasca R, Valentinis B et al. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. J. Pathol. 1995; 176: 45-53.
15. Norton AJ, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues. J. Pathol. 1994; 173: 371-379.
16. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 1984; 133: 1710-1715.
17. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formaline-fixed paraffin sections. J. Pathol. 1992; 168: 357-363.
18. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB 1. Histopathology 1993; 22: 355-360.
19. Pellicer EM, Sundblad A. Antigen retrieval by microwave oven with buffer of citric acid. Medicina (B. Aires) 1994; 54: 129-132.
20. Pinder SE, Wencyk P, Sibbering DM et al. Assessment of the new proliferation marker MIB 1 in breast carcinoma using image analysis: Associations with other prognostic factors and survival. Br. J. Cancer 1995; 71: 146-149.
21. Barbareschi M, Girlando S, Mauri FM et al. Quantitative growth fraction evaluation with MIB-1 and Ki67 antibodies in breast carcinomas. Am. J. Clin. Pathol. 1994; 102: 171-175.
22. Beck T, Weller EE, Weikel W, Brumm C, Wilkens C, Knapstein PG. Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: Correlations with established prognosis parameters and with the proliferation marker, MIB-1. Gynecol. Oncol. 1995; 57: 96-104.
23. Gersell DJ, Katzenstein AA. Spindle cell carcinoma of the breast: A clinicopathologic and ultrastructural study. Hum. Pathol. 1981; 12: 550-561.
24. Bauer TW, Rostock RA, Eggleston JC et al. Spindle cell carcinoma of the breast: Four cases and review of the literature. Hum. Pathol. 1984; 15: 147-152.
25. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. I: Matrix-producing carcinoma. Hum. Pathol. 1989; 20: 628-635.